The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy. (SHOR-TEST)
Prostate Cancer
About this trial
This is an interventional basic science trial for Prostate Cancer focused on measuring prostate neoplasm, exercise, high intensity interval training, tumor hypoxia, immune cells
Eligibility Criteria
Inclusion Criteria:
- Men with histologically verified localized prostate adenocarcinoma undergoing curative intended radical prostatectomy.
Exclusion Criteria:
- Age: <18 years
- Any other known malignancy requiring active treatment
- Performance status > 1
- Allergy to pimonidazole
- Ongoing treatment with beta blockers
- Physical disabilities precluding physical testing and/or exercise
- Inability to read and understand Danish
Sites / Locations
- Center for Physical Activity Research, Copenhagen University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
High Intensity Interval Training bout
Controls (usual care)
Patients randomized to this group will perform a wattmax test immediately followed by 4 intervals of high and low intensity based on percentage of wattmax. Immediately after the exercise bout is finished patients will receive one dose of pimonidazole hydrochloride (500 mg per m2 body surface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate by radical prostatectomy the following day.
Patients randomized to the control group will not be doing any exercise, but will after approximately 35 min from baseline blood sampling receive one dose of pimonidazole hydrochloride (500 mg per m2 bodysurface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate by radical prostatectomy the following day.